related documents Somatostatin-based Radiopeptide Therapy with [Lu-177-DOTA]-TOC versus [Y-90-DOTA]-TOC in Neuroendocrine Tumors Conferences Somatostatin-based Radiotherapy with [Y-90-DOTA]-TOC in Neuroendocrine Tumors: Long-Term Outcome of a Phase I Dose Escalation Study Conferences